These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22340130)

  • 1. Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study.
    Chamnan P; Simmons RK; Khaw KT; Wareham NJ; Griffin SJ
    Diabet Med; 2012 Jul; 29(7):893-904. PubMed ID: 22340130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study.
    Chamnan P; Simmons RK; Khaw KT; Wareham NJ; Griffin SJ
    BMJ; 2010 Apr; 340():c1693. PubMed ID: 20418545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the european prospective investigation of cancer-norfolk cohort: implications for preventive strategies.
    Chamnan P; Simmons RK; Forouhi NG; Luben RN; Khaw KT; Wareham NJ; Griffin SJ
    Diabetes Care; 2011 Apr; 34(4):950-6. PubMed ID: 20622160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark.
    Lauritzen T; Sandbaek A; Skriver MV; Borch-Johnsen K
    Diabetologia; 2011 Jun; 54(6):1318-26. PubMed ID: 21340624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study.
    Pajunen P; Peltonen M; Eriksson JG; Ilanne-Parikka P; Aunola S; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J; Lindström J;
    Diabet Med; 2011 Jan; 28(1):36-42. PubMed ID: 21166843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
    Jesudason DR; Dunstan K; Leong D; Wittert GA
    Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
    Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
    Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index.
    Thomas C; Hyppönen E; Power C
    Arch Intern Med; 2006 Mar; 166(6):682-8. PubMed ID: 16567609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
    Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
    Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
    Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
    Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study.
    Sandbaek A; Griffin SJ; Rutten G; Davies M; Stolk R; Khunti K; Borch-Johnsen K; Wareham NJ; Lauritzen T
    Diabetologia; 2008 Jul; 51(7):1127-34. PubMed ID: 18443762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting.
    Gray LJ; Davies MJ; Hiles S; Taub NA; Webb DR; Srinivasan BT; Khunti K
    Diabetologia; 2012 Apr; 55(4):959-66. PubMed ID: 22231125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for type 2 diabetes. Lessons from the ADDITION-Europe study.
    van den Donk M; Sandbaek A; Borch-Johnsen K; Lauritzen T; Simmons RK; Wareham NJ; Griffin SJ; Davies MJ; Khunti K; Rutten GE
    Diabet Med; 2011 Nov; 28(11):1416-24. PubMed ID: 21679235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006?
    Cosson E; Nguyen MT; Hamo-Tchatchouang E; Banu I; Chiheb S; Charnaux N; Valensi P
    Diabet Med; 2011 May; 28(5):567-74. PubMed ID: 21480967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
    Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
    Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.
    Simmons RK; Echouffo-Tcheugui JB; Sharp SJ; Sargeant LA; Williams KM; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ
    Lancet; 2012 Nov; 380(9855):1741-8. PubMed ID: 23040422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HbA(1c) measurement for the diagnosis of diabetes: is it enough?
    Cavagnolli G; Comerlato J; Comerlato C; Renz PB; Gross JL; Camargo JL
    Diabet Med; 2011 Jan; 28(1):31-5. PubMed ID: 21210540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.
    Bhowmik B; Diep LM; Munir SB; Rahman M; Wright E; Mahmood S; Afsana F; Ahmed T; Khan AK; Hussain A
    Diabet Med; 2013 Mar; 30(3):e70-7. PubMed ID: 23199158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Record-based, stepwise screening for type 2 diabetes integrated into an annual cardiovascular care review system: Findings from a UK general practice.
    Fisher BG; Ang YL; Goodhart C; Simmons RK
    Prim Care Diabetes; 2011 Dec; 5(4):265-9. PubMed ID: 21968319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.